NEWBRY — Newbury Pharmaceuticals AB Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Newbury Pharmaceuticals AB, fiscal year end - August 31st, SEK millions except per share, conversion factor applied.

	2021 August 31st	2022 August 31st	2023 August 31st
Period Length:	—	—	—
Source:	ARS	ARS	ARS
Standards:	SAS	SAS	SAS
Status:	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	13.1	33.3	8.53
Net Total Accounts Receivable
Net Total Receivables	2.33	0.791	15.5
Total Inventory
Prepaid Expenses
Total Current Assets	15.8	36.5	27.2
Net Goodwill
Net Intangible Assets
Total Assets	42.8	86.9	72.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.34	6.06	11.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.34	18.1	23.5
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.5	68.8	49.4
Total Liabilities & Shareholders' Equity	42.8	86.9	72.9
Total Common Shares Outstanding